Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Estrogen for Postoperative Experience in Transgender Men Undergoing Hysterectomy
NCT06969326Phase 3Recruiting
- Sponsor
- Women & Infants Hospital
- Start
- May 2025
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of estradiol topical in postoperative hemorrhage (2 arms), sponsored by Women & Infants Hospital. Primary endpoints: Number of postoperative health system contacts for vaginal bleeding at 2 weeks, Number of days of bleeding at 6 weeks and 1 more. Started May 2025; status: recruiting.
02
Drugs
estradiol topical
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on NCT06969326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06969326.